Ensysce Biosciences (ENSC) Short Interest Ratio & Short Volume $2.18 +0.10 (+4.81%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$2.13 -0.05 (-2.34%) As of 08/8/2025 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Ensysce Biosciences Short Interest DataEnsysce Biosciences (ENSC) has a short interest of 159,400 shares. This marks a -41.57% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 882,421 shares to cover all short positions.Current Short Interest159,400 sharesPrevious Short Interest272,800 sharesChange Vs. Previous Month-41.57%Dollar Volume Sold Short$336.33 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares2,370,000 sharesPercentage of Shares Shorted6.73%Today's Trading Volume117,906 sharesAverage Trading Volume882,421 sharesToday's Volume Vs. Average13% Short Selling Ensysce Biosciences? Sign up to receive the latest short interest report for Ensysce Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENSC Short Interest Over TimeENSC Days to Cover Over TimeENSC Percentage of Float Shorted Over Time Ensysce Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2025159,400 shares $336.33 thousand -41.6%N/A0.1 $2.11 6/30/2025272,800 shares $608.34 thousand -7.0%12.5%0.2 $2.23 6/15/2025293,200 shares $606.92 thousand +199.2%13.4%0.2 $2.07 5/31/202598,000 shares $214.62 thousand -71.5%8.1%0.1 $2.19 5/15/2025344,400 shares $737.02 thousand +138.3%28.6%0.2 $2.14 4/30/2025144,500 shares $436.39 thousand +7.1%N/A0.1 $3.02 4/15/2025134,900 shares $302.18 thousand +328.3%11.2%0.1 $2.24 3/31/202531,500 shares $80.64 thousand +43.2%2.6%0.8 $2.56 3/15/202522,000 shares $85.58 thousand -43.3%1.8%0.4 $3.89 2/28/202538,800 shares $209.13 thousand -1.0%3.2%0.5 $5.39 Get the Latest News and Ratings for ENSC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ensysce Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/202539,200 shares $227.36 thousand +3.7%3.3%0.4 $5.80 1/31/202537,800 shares $259.69 thousand -31.2%N/A0.1 $6.87 1/15/202554,900 shares $393.08 thousand -35.2%N/A0 $7.16 12/31/202484,700 shares $689.46 thousand +85.8%N/A0 $8.14 12/15/202445,600 shares $256.27 thousand -60.5%N/A0 $5.62 11/30/2024115,300 shares $854.37 thousand -97.6%N/A0.1 $7.41 11/15/20244,850,000 shares $3.25 million -23.6%N/A0.2 $0.67 10/31/20246,350,000 shares $3.66 million +5,514.5%43.4%0.2 $0.58 10/15/2024113,100 shares $19.05 thousand -37.2%0.8%0 $0.17 9/30/2024180,200 shares $43.25 thousand -11.4%1.6%0.1 $0.24 9/15/2024203,300 shares $66.28 thousand -70.5%1.9%0.1 $0.33 8/31/2024689,400 shares $272.31 thousand +3,885.0%6.3%0.4 $0.40 8/15/202417,300 shares $6.80 thousand -92.7%0.2%0.2 $0.39 7/31/2024235,500 shares $105.98 thousand +2.5%3.2%1.7 $0.45 7/15/2024229,800 shares $106.05 thousand -16.6%3.2%1.7 $0.46 6/30/2024275,500 shares $139.54 thousand +4.0%3.8%2 $0.51 6/15/2024264,800 shares $137.70 thousand +37.1%3.6%1.8 $0.52 5/31/2024193,200 shares $111.09 thousand +40.0%2.7%1.4 $0.58 5/15/2024138,000 shares $85.44 thousand +1,337.5%1.9%0.9 $0.62 4/30/20249,600 shares $5.68 thousand +134.2%0.1%0 $0.59 4/15/20244,100 shares $2.79 thousand -76.6%0.1%0 $0.68 3/31/202417,500 shares $13.83 thousand -69.0%0.6%0 $0.79 3/15/202456,500 shares $44.84 thousand -34.4%1.9%0 $0.79 2/29/202486,100 shares $80.28 thousand +40.9%3.0%0.1 $0.93 2/15/202461,100 shares $54.38 thousand -91.0%2.1%0 $0.89 1/31/2024678,500 shares $1.10 million +175.5%23.3%0.5 $1.62 1/15/2024246,300 shares $337.43 thousand +9.1%8.8%0.2 $1.37 12/31/2023225,700 shares $239.24 thousand +35.2%8.0%1 $1.06 12/15/2023167,000 shares $185.37 thousand +25.3%5.9%0.8 $1.11 11/30/2023133,300 shares $151.96 thousand +96.6%4.8%0.9 $1.14Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here 11/15/202367,800 shares $59.81 thousand +11.3%2.4%0.9 $0.88 10/31/202360,900 shares $56.09 thousand +161.4%2.2%0.8 $0.92 10/15/202323,300 shares $33.55 thousand +9.9%0.9%0.3 $1.44 9/30/202321,200 shares $29.26 thousand -20.0%0.8%0.4 $1.38 9/15/202326,500 shares $46.38 thousand -4.0%1.1%0.1 $1.75 8/31/202327,600 shares $51.06 thousand -2.1%1.1%0.1 $1.85 8/15/202328,200 shares $54.99 thousand -36.8%1.0%0.1 $1.95 7/31/202344,600 shares $89.65 thousand +81.3%1.9%0.1 $2.01 7/15/202324,600 shares $48.22 thousand +24.9%1.4%0 $1.96 6/30/202319,700 shares $36.05 thousand -2.5%2.4%0 $1.83 6/15/202320,200 shares $47.47 thousand +6.3%2.5%0 $2.35 5/31/202319,000 shares $45.03 thousand -83.3%2.3%0 $2.37 5/15/2023113,600 shares $349.89 thousand +43.8%11.0%0.2 $3.08 4/30/202379,000 shares $296.25 thousand +62.2%6.3%0.1 $3.75 4/15/202348,700 shares $194.37 thousand +5.9%3.9%0.2 $3.99 3/31/202346,000 shares $2.68 million -92.1%6.9%0.2 $58.32 3/15/2023580,700 shares $351.90 thousand +194.3%17.3%0.3 $0.61 2/28/2023197,300 shares $96.48 thousand -28.3%5.7%0.1 $0.49 2/15/2023275,200 shares $167.87 thousand -47.6%7.2%0.1 $0.61 1/31/2023525,000 shares $367.50 thousand +631.2%9.9%0.2 $0.70 1/15/202371,800 shares $55.32 thousand -9.9%1.6%0 $0.77 12/30/202279,700 shares $59.78 thousand -44.4%1.7%0.1 $0.75 12/15/2022143,400 shares $131.34 thousand -54.6%7.1%0.1 $0.92 11/30/2022315,700 shares $915.53 thousand +128.9%17.3%0.3 $2.90 11/15/2022137,900 shares $297.86 thousand -8.1%7.5%0.2 $2.16 10/31/2022150,000 shares $484.50 thousand -78.5%10.1%0.8 $3.23 10/15/2022698,700 shares $144.63 thousand -39.8%3.2%0.5 $0.21 9/30/20221,160,000 shares $249.40 thousand -27.5%5.3%1.1 $0.22 9/15/20221,600,000 shares $551.84 thousand +134.6%7.4%1 $0.34 8/31/2022681,900 shares $288.03 thousand -5.0%3.3%0.5 $0.42 8/15/2022717,500 shares $350.21 thousand +30.6%3.5%0.6 $0.49 7/31/2022549,200 shares $282.78 thousand -12.1%2.9%0.5 $0.51 7/15/2022624,900 shares $365.63 thousand +20.0%3.3%0.5 $0.59 6/30/2022520,600 shares $452.09 thousand +45.0%2.9%0.4 $0.87 6/15/2022359,100 shares $169.14 thousand +52.9%2.0%0.4 $0.47 5/31/2022234,800 shares $131.65 thousand +94.7%1.5%0.2 $0.56 5/15/2022120,600 shares $81.01 thousand -83.4%0.9%0.1 $0.67 4/30/2022724,300 shares $796.73 thousand +65.0%7.6%0.9 $1.10 4/15/2022439,000 shares $469.73 thousand +41.5%4.6%0.6 $1.07 3/31/2022310,200 shares $353.63 thousand +139.7%4.0%0.3 $1.14 3/15/2022129,400 shares $139.75 thousand -64.0%1.7%0.1 $1.08 2/28/2022359,300 shares $402.42 thousand +154.5%4.7%0.1 $1.12 2/15/2022141,200 shares $211.80 thousand -59.6%1.8%0 $1.50 1/31/2022349,700 shares $608.48 thousand +229.9%4.5%0 $1.74 1/15/2022106,000 shares $347.68 thousand -86.8%N/A0 $3.28 12/31/2021801,600 shares $3.77 million -7.7%10.4%0.1 $4.70 12/15/2021868,100 shares $3.57 million +702.3%11.2%0.1 $4.11 11/30/2021108,200 shares $170.96 thousand +18.1%1.4%0 $1.58 11/15/202191,600 shares $196.02 thousand -58.3%1.2%0.1 $2.14 10/29/2021219,900 shares $483.78 thousand +140.3%2.8%0.2 $2.20Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here 10/15/202191,500 shares $216.86 thousand -38.8%1.2%0 $2.37 9/30/2021149,400 shares $452.68 thousand +280.2%1.6%0.1 $3.03 9/15/202139,300 shares $120.65 thousand -20.1%0.4%0 $3.07 8/31/202149,200 shares $155.47 thousand +59.7%0.5%0 $3.16 8/13/202130,800 shares $101.02 thousand No Change0.3%0 $3.28 ENSC Short Interest - Frequently Asked Questions What is Ensysce Biosciences' current short interest? Short interest is the volume of Ensysce Biosciences shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 159,400 shares of ENSC short. Learn More on Ensysce Biosciences' current short interest. Is Ensysce Biosciences' short interest increasing or decreasing? Ensysce Biosciences saw a decrease in short interest in the month of July. As of July 15th, there was short interest totaling 159,400 shares, a decrease of 41.6% from the previous total of 272,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ensysce Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Ensysce Biosciences: Chemomab Therapeutics Ltd. Sponsored ADR (1.03%), BioAtla, Inc. (7.27%), Passage Bio, Inc. (4.04%), Synlogic, Inc. (0.40%), Hoth Therapeutics, Inc. (3.05%), Lipocine Inc. (1.93%), Lexaria Bioscience Corp. (2.92%), BioLineRx Ltd. (4.48%), CASI Pharmaceuticals Inc. (0.70%), Mannatech, Incorporated (0.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Ensysce Biosciences stock? Short selling ENSC is an investing strategy that aims to generate trading profit from Ensysce Biosciences as its price is falling. ENSC shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ensysce Biosciences? A short squeeze for Ensysce Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENSC, which in turn drives the price of the stock up even further. How often is Ensysce Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENSC, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Chemomab Therapeutics Short Interest BioAtla Short Interest Passage Bio Short Interest Synlogic Short Interest Hoth Therapeutics Short Interest Lipocine Short Interest Lexaria Bioscience Short Interest BioLineRx Short Interest CASI Pharmaceuticals Short Interest Mannatech Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENSC) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ensysce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ensysce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
